GB2394953B - Inhibition of replication factor C - Google Patents

Inhibition of replication factor C

Info

Publication number
GB2394953B
GB2394953B GB0404039A GB0404039A GB2394953B GB 2394953 B GB2394953 B GB 2394953B GB 0404039 A GB0404039 A GB 0404039A GB 0404039 A GB0404039 A GB 0404039A GB 2394953 B GB2394953 B GB 2394953B
Authority
GB
United Kingdom
Prior art keywords
inhibition
replication factor
replication
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0404039A
Other versions
GB2394953A (en
GB0404039D0 (en
Inventor
Neil Donald Perkins
Lisa Ann Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Publication of GB0404039D0 publication Critical patent/GB0404039D0/en
Publication of GB2394953A publication Critical patent/GB2394953A/en
Application granted granted Critical
Publication of GB2394953B publication Critical patent/GB2394953B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0404039A 2001-08-29 2002-08-29 Inhibition of replication factor C Expired - Fee Related GB2394953B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120943.6A GB0120943D0 (en) 2001-08-29 2001-08-29 Inhibition of replication factor C
PCT/GB2002/003953 WO2003020754A2 (en) 2001-08-29 2002-08-29 Inhibition of replication factor c

Publications (3)

Publication Number Publication Date
GB0404039D0 GB0404039D0 (en) 2004-03-31
GB2394953A GB2394953A (en) 2004-05-12
GB2394953B true GB2394953B (en) 2005-12-14

Family

ID=9921170

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0120943.6A Ceased GB0120943D0 (en) 2001-08-29 2001-08-29 Inhibition of replication factor C
GB0404039A Expired - Fee Related GB2394953B (en) 2001-08-29 2002-08-29 Inhibition of replication factor C

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0120943.6A Ceased GB0120943D0 (en) 2001-08-29 2001-08-29 Inhibition of replication factor C

Country Status (3)

Country Link
AU (1) AU2002321556A1 (en)
GB (2) GB0120943D0 (en)
WO (1) WO2003020754A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0303397D0 (en) * 2003-12-17 2003-12-17 Index Pharmaceuticals Ab Compounds and method for RNA interference

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
EMBO J., VOL 15, 1996, R FOTEDAR ET AL, 4423-4433 *
EMBO J., VOL 16, 1997, E RHEAUME ET AL, 6346-6354 *
J BIOLOGICAL CHEMISTRY, VOL 275, 2000, NR CHAPMAN ET AL, 4719-4725 *
J BIOLOGICAL CHEMISTRY, VOL 277, 2002, LA ANDERSON ET AL, 29550-29554 *
MOLECULAR & CELLULAR BIOLOGY, VOL 23, 2003, LA ANDERSON & ND PERKINS, 721-732 *
MOLECULAR CELL, VOL 4, 2001, V PENNANEACH ET AL, 715-727 *
NATURE, VOL 411, 2001, SM ELBASHIR ET AL, 494-498 *

Also Published As

Publication number Publication date
WO2003020754A3 (en) 2003-05-15
AU2002321556A1 (en) 2003-03-18
GB2394953A (en) 2004-05-12
GB0120943D0 (en) 2001-10-17
GB0404039D0 (en) 2004-03-31
WO2003020754A2 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
ZA200501913B (en) New compounds for the inhibition of rotamases and use thereof
AU2002339348A1 (en) Inhibition of STAT-1
GB0025782D0 (en) Use of inhibitors
AU2002360437A8 (en) Reducing myelin-mediated inhibition of axon regeneration
EP1390052A4 (en) Inhibition of jun kinase
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
IL188485A0 (en) New use of iloperidone
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
GB2394953B (en) Inhibition of replication factor C
AU2003299137A8 (en) Inhibition of metallo-beta-lactamase
AU2003287388A8 (en) Inhibition of hiv-1 replication
GB0100151D0 (en) Methods of sputtering
HK1053059A1 (en) New use of imidazotriazinon derivatives
IL156839A0 (en) Use of chromanes
GB0126000D0 (en) Use of 4ñ Phorbol
AU2002307475A1 (en) Inhibition of jun kinase
HU0104370D0 (en) Honeyed schnaps of oerseg
GB0126214D0 (en) Inhibition of hyperproliferation
GB0021927D0 (en) Use of pharmaceutical combination
GB0117481D0 (en) Bathroom aid
AU2002305360A1 (en) Therapeutic compisitions and methods for the inhibition of angiogenesis
GB0108962D0 (en) Use of films
PL112031U1 (en) Set of furniture segments

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20110829